Downloadable Slidesets

Share

Program Content

Activities

  • <i>MET</i> Mutations in NSCLC
    MET Mutations: Mastering the Features of and Testing for a New Target in NSCLC
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 29, 2020

    Expires: May 28, 2021

  • MET TKIs in <i>MET</i>ex14+ NSCLC: Tepotinib
    MET-Targeted Therapies in Development: Tepotinib, Crizotinib, Savolitinib, and Combinations
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 29, 2020

    Expires: May 28, 2021

  • MET TKIs in <i>MET</i>ex14+ NSCLC: Capmatinib
    MET-Targeted Therapies in Development: Capmatinib, Acquired Resistance to MET TKIs, and Next-Line Choices
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 29, 2020

    Expires: May 28, 2021

Faculty

cover img faculity

Luis Paz-Ares, MD, PhD

Chair of the Medical Oncology Department
Hospital Universitario 12 de Octubre
Associate Professor
Universidad Complutense de Madrid
Head of the Lung Cancer Unit
CNIO (Spanish National Cancer Research Center)
Madrid, Spain

cover img faculity

Karen L. Reckamp, MD, MS

Associate Professor
Medical Oncology and Therapeutics Research
City of Hope Comprehensive Cancer Center
Duarte, California

Provided by

ProCE Banner

Supporters

Merck KGaA